Updated: May 19, 2026

Hannah Valantine

BBIOBridgeBio Pharma, Inc.SEC CIK: 0001855608
Estimated Net Worth
$3.52 Million32.3%vs Last Year
Last Updated: May 19, 2026 11:50 PM EST

Transaction Summary

Total Transactions38
Buy-Sell Ratio2.18
Buy Transactions24
Sell Transactions11

Transaction Volume

Total Volume$2.52M
Net Volume-$2.18M
Buy Volume$169.03K
Sell Volume$2.35M

Trade Analysis

AVG Trade Size$66.23K
Largest Trade$483.08K
Most Active MonthJun
Most Active Year2021

Trading Sentiment

OverallBearish
Recent TradeSelling
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Hannah Valantine has an estimated net worth of $3.52 Million. This is based on reported shares across multiple companies, which include CareDx, Inc., PACIFIC BIOSCIENCES OF CALIFORNIA, INC., and BridgeBio Pharma, Inc..



2021 was Hannah Valantine's most active year for acquiring shares with 12 total transactions. Hannah Valantine's most active month to acquire stocks was the month of May. 2025 was Hannah Valantine's most active year for disposing of shares, totalling 11 transactions. Hannah Valantine's most active month to dispose stocks was the month of May. 2025 saw Hannah Valantine paying a total of $1,522,247.05 for 134,768 shares, this is the most they've acquired in one year. In 2025 Hannah Valantine cashed out on 100,579 shares for a total of $2,684,800.42, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…
Loading…